Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), eta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.338 | 0.338 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.2097 | 0.4775 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.338 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.1004 | 0.1004 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.1004 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.1004 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.338 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.338 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.338 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.1004 | 0.2969 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.1004 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0054 | 0.3293 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0054 | 0.3293 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.1004 | 0.2969 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.338 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.1004 | 0.2969 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.1004 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.1004 | 0.2969 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.3293 | 0.3293 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.1004 | 0.1904 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.2097 | 0.4775 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.1004 | 0.1904 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.1004 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0054 | 0.3293 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.338 | 0.338 |
Echinococcus granulosus | dna polymerase eta | 0.0054 | 0.3293 | 0.9742 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.1004 | 0.2969 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.1004 | 0.1004 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.1004 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.1004 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0054 | 0.3293 | 0.3293 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.1004 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0054 | 0.3293 | 0.9742 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.2097 | 0.5 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.1004 | 0.2969 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1004 | 0.1904 |
Echinococcus multilocularis | dna polymerase eta | 0.0054 | 0.3293 | 0.9742 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.338 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.338 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.1004 | 0.1904 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.1004 | 0.1904 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.